Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese han population: A case-control study

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 9, 2013, Pages 707-712

  Wu, Hai Di ^a   Bai, Xiao ^b   Chen, Dong Mei ^a   Cao, Hong Yan ^a   Qin, Ling ^a  

^a JILIN UNIVERSITY   (China)

^b Basic Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GENOMIC DNA; MMP9 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE ISOLATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOSYNTHESIS; BLOOD; CHINA; ENZYMOLOGY; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84883718812     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0109     Document Type: Article

References (30)

1. Bendeck MP, Zempo N, Clowes AW, et al. (1994) Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545. (Pubitemid 24256415)
2. Birkedal-Hansen H, Moore WG, Bodden MK, et al. (1993) Matrix metalloproteinases: areview. Crit Rev Oral Biol Med 4:197-250.
3. Blankenberg S, Rupprecht HJ, Poirier O, et al. (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-1585. (Pubitemid 36397324)
4. Brown DL, Hibbs MS, Kearney M, et al. (1995) Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91:2125-2131.
5. Chinese Medical Cardiology Subcommittee, Chinese Editorial Committee of Cardiology Journal (2007) Chinese guidelines for the diagnosis and treatment of patients with unstable angina and non ST-elevation myocardial infarction. Chin J Cardiol 35:295-304.
6. Chinese Medical Cardiology Subcommittee, Chinese Editorial Committee of Cardiology Journal (2010) Chinese guidelines for the diagnosis and treatment of patients with ST-elevation myocardial infarction. Chin J Cardiol 38:675-690.
7. Gai X, Lan X, Luo Z, et al. (2009) Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients. Clin Chim Acta 408:105-109.
8. Galis ZS, Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90:251-262. (Pubitemid 34633925)
9. Heeneman S, Cleutjens JP, Faber BC, et al. (2003) The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 200:516-525. (Pubitemid 36818252)
10. Henney AM, Ye S, Zhang B, et al. (2000) Genetic diversity in the matrix metalloproteinase family. Effects on function and disease progression. Ann N Y Acad Sci 902:27-38. (Pubitemid 30389108)
11. Koh YS, Chang K, Kim PJ, et al. (2008) A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction. Int J Cardiol 127:430-432. (Pubitemid 351885094)
12. Loftus IM, Naylor AR, Goodall S, et al. (2000) Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke 31:40-47. (Pubitemid 30035750)
13. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125.
14. Morgan AR, Zhang B, Tapper W, et al. (2003) Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med (Berl) 81:321-326. (Pubitemid 36718329)
15. Nanni S, Melandri G, Hanemaaijer R, et al. (2007) Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Transl Res 149:137-144. (Pubitemid 46275571)
16. Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85:1-31. (Pubitemid 40171256)
17. Newby AC, Zaltsman AB (1999) Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 41:345-360. (Pubitemid 29087331)
18. Opstad TB, Pettersen AA, Weiss TW, et al. (2012) Genetic variation, gene-expression and circulation levels of matrix metalloproteinase-9 in patients with stable coronary artery disease. Clin Chim Acta 413:113-120.
19. Robertson L, Grip L, Mattsson Hulte L, et al. (2007) Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention. J Intern Med 262:659-667. (Pubitemid 350135190)
20. Saedi M, Vaisi-Raygani A, Khaghani S, et al. (2012) Matrix metalloproteinase-9 functional promoter polymorphism 1562 C/T increased risk of early-onset coronary artery disease. Mol Biol Rep 39:555-562.
21. Shipley JM, Doyle GA, Fliszar CJ, et al. (1996) The structural basis for the elastolytic activity of the 92 and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 271:4335-4341.
22. Spurthi KM, Galimudi RK, Srilatha G, et al. (2012) Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis. Genet Test Mol Biomarkers 16:850-854.
23. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839. (Pubitemid 36542523)
24. Weiss TW, Furenes EB, Trøseid M, et al. (2010) Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men. Thromb Haemost 103:679-681.
25. Wu S, Hsu LA, Teng MS, et al. (2010) Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentration in Taiwanese individuals. Clin Chem Lab Med 48:543-549.
26. Yasmin, McEniery CM, O'Shaughnessy KM, et al. (2006) Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals. Arterioscler Thromb Vasc Biol 26:1799-1805. (Pubitemid 44305333)
27. Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623-629.
28. Zhang B, Henney A, Eriksson P, et al. (1999a) Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105:418-423.
29. Zhang B, Ye S, Herrmann SM, et al. (1999b) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788-1794. (Pubitemid 29181405)
30. Zhi H, Wang H, Ren L, et al. (2010) Functional polymorphisms of matrix metalloproteinase-9 and risk of coronary artery disease in a Chinese population. Mol Biol Rep 37:13-20.